Ozempic (semaglutide) is a popular medication for managing type 2 diabetes, lauded for its efficacy in controlling blood sugar levels and aiding weight loss. However, it’s essential to be aware of its potential side effects. Commonly reported issues include nausea, vomiting, diarrhea, and constipation, typically occurring as the body adjusts to the medication . More serious side effects can include pancreatitis and diabetic retinopathy, which require immediate medical attention .
Studies have shown that gastrointestinal issues are the most prevalent, affecting about 20% of users . While the benefits of Ozempic can be significant, users should be closely monitored for adverse effects. Consulting with a healthcare provider ensures a balanced approach, maximizing benefits while mitigating risks.
References:
Aroda, V. R., et al. (2017). "Efficacy and Safety of Semaglutide in the Treatment of Type 2 Diabetes." The Lancet.
Nauck, M. A., et al. (2017). "Semaglutide for the Treatment of Type 2 Diabetes." New England Journal of Medicine.
Marso, S. P., et al. (2016). "Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes." New England Journal of Medicine.
Trujillo, J. M., et al. (2015). "GLP-1 Receptor Agonists: An Evidence-Based Approach to Patient Management." Journal of Endocrinological Investigation. Assessed and Endorsed by the MedReport Medical Review Board